Skip to content

Clinical trials

Phase 1 Neoplasm Metastasis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1 Country / region: Germany Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20081
20112
20122
20132
20152
20164
20171
20182
20192
20205
20212
20221
20232
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated7
Active, not recruiting5
Recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company8
Novartis Pharmaceuticals4
Bayer3
AbbVie2
Boehringer Ingelheim1
Celgene1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
GSO Global Clinical Research BV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis35
Colorectal Neoplasms9
Neoplasms9
Carcinoma, Non-Small-Cell Lung6
Breast Neoplasms3
Colonic Neoplasms3
Rectal Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Carcinoma, Hepatocellular2
Endometrial Neoplasms2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.